Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials (Q45323629)
Jump to navigation
Jump to search
scientific article published on 4 December 2017
- Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials |
scientific article published on 4 December 2017 |
|
Statements
1 reference
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials (English)
1 reference
Theodore C Pierson
1 reference
John R Mascola
1 reference
Kimberly A Dowd
1 reference
Srilatha Edupuganti
1 reference
Josephine H Cox
1 reference
Barney S Graham
1 reference
Julie E Ledgerwood
1 reference
Nadine G Rouphael
1 reference
Kirsten E Lyke
1 reference
Ingelise J Gordon
1 reference
Kaitlyn M Morabito
1 reference
Katherine Burgomaster
1 reference
LaSonji A Holman
1 reference
Cynthia S Hendel
1 reference
Richard M Schwartz
1 reference
Rebecca S Pelc
1 reference
Laura Novik
1 reference
Nina Berkowitz
1 reference
Galina Yamshchikov
1 reference
Bryant M Foreman
1 reference
Christina R DeMaso
1 reference
Katherine V Houser
1 reference
Ro Shauna Rothwell
1 reference
Floreliz Mendoza
1 reference
Sandra Sitar
1 reference
Carolyn Laurencot
1 reference
Zonghui Hu
1 reference
Jamie G Saunders
1 reference
Monica A McArthur
1 reference
Ginny E Cummings
1 reference
Robert T Bailer
1 reference
David N Gordon
1 reference
Grace L Chen
1 reference
VRC 319
1 reference
VRC 320 study teams
1 reference
4 December 2017
1 reference
1 reference
391
0 references
552-562
0 references
10120
0 references
1 reference